Global Information
회사소개 | 문의 | 비교리스트

조직진단 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2022-2027년)

Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

리서치사 IMARC Services Private Limited
발행일 2022년 09월 상품코드 1127893
페이지 정보 영문 108 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 2,499 ₩ 3,613,000 PDF (Single User License)
US $ 3,499 ₩ 5,058,000 PDF (5 User License)
US $ 4,499 ₩ 6,504,000 PDF (Corporate License)


조직진단 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2022-2027년) Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
발행일 : 2022년 09월 페이지 정보 : 영문 108 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 조직진단 시장 규모는 2021년에 48억 달러에 달했습니다. 향후 IMARC 그룹은 2022-2027년 7.1%의 성장률(CAGR)을 보이며, 2027년까지 72억 달러에 달할 것으로 예측하고 있습니다. COVID-19의 불확실성을 염두에 두고 우리는 팬데믹이 다양한 최종 사용 부문에 미치는 직접적 및 간접적 영향을 계속 추적·평가하고 있습니다. 이 인사이트는 시장의 주요 기여 요소로서 리포트에 포함되어 있습니다.

목차

제1장 서문

제2장 조사 방법과 범위

  • 조사의 목적
  • 이해관계자
  • 데이터 소스
    • 1차 정보
    • 2차 정보
  • 시장 추정
    • 보텀업 어프로치
    • 톱다운 어프로치
  • 예측 방법

제3장 개요

제4장 서론

  • 개요
  • 주요 산업 동향

제5장 세계의 조직진단 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 제품 유형별 시장 내역
  • 기술별 시장 내역
  • 질환별 시장 내역
  • 최종사용자별 시장 내역
  • 지역별 시장 내역
  • 시장 예측

제6장 제품 유형별 시장 내역

  • 기기
    • 시장 동향
    • 시장 전망
  • 소모품
    • 시장 동향
    • 시장 예측

제7장 테크놀러지별 시장 내역

  • 면역조직화학
    • 시장 동향
    • 시장 예측
  • In Situ 하이브리다이제이션
    • 시장 동향
    • 시장 예측
  • 디지털 병리학과 워크플로우 관리
    • 시장 동향
    • 시장 예측
  • 특수 염색
    • 시장 동향
    • 시장 예측

제8장 질환별 시장 내역

  • 유방암
    • 시장 동향
    • 시장 전망
  • 위암
    • 시장 동향
    • 시장 예측
  • 림프종
    • 시장 동향
    • 시장 예측
  • 전립선암
    • 시장 동향
    • 시장 예측
  • 비소세포폐암
    • 시장 동향
    • 시장 예측
  • 기타
    • 시장 동향
    • 시장 예측

제9장 최종사용자별 시장 내역

  • 병원
    • 시장 동향
    • 시장 예측
  • 조사 연구기관
    • 시장 동향
    • 시장 예측
  • 제약회사
    • 시장 동향
    • 시장 예측
  • 임상시험수탁기관(CRO)
    • 시장 동향
    • 시장 예측
  • 기타
    • 시장 동향
    • 시장 예측

제10장 지역별 시장 내역

  • 북미
    • 시장 동향
    • 시장 예측
  • 유럽
    • 시장 동향
    • 시장 전망
  • 아시아태평양
    • 시장 동향
    • 시장 예측
  • 중동·아프리카 지역
    • 시장 동향
    • 시장 전망
  • 라틴아메리카
    • 시장 동향
    • 시장 전망

제11장 SWOT 분석

  • 개요
  • 강점
  • 약점
  • 기회
  • 위협

제12장 밸류체인 분석

제13장 Porter의 산업 분석

  • 개요
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 경쟁의 정도
  • 신규 진출업체의 위협
  • 대체품의 위협

제14장 가격 분석

  • 가격 지표
  • 가격 구조
  • 마진 분석

제15장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • Sakura Finetek Japan
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
KSA 22.09.29

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2021
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2021
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2021
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2021
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2021
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2022-2027
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2022-2027
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players

The global tissue diagnostics market size reached US$ 4.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2027, exhibiting a growth rate (CAGR) of 7.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

  • Instruments
  • Consumables

Breakup by Technology:

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Breakup by Disease:

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report:

  • How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global tissue diagnostics industry?
  • What has been the impact of COVID-19 on the global tissue diagnostics industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global tissue diagnostics industry?
  • What are the key driving factors and challenges in the global tissue diagnostics industry?
  • What is the structure of the global tissue diagnostics industry and who are the key players?
  • What is the degree of competition in the global tissue diagnostics industry?
  • What are the profit margins in the global tissue diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology
Back to Top
전화 문의
F A Q